المؤلفون: Rivera FB; Department of Medicine, Lincoln Medical Center, New York, NY, USA., Arias-Aguirre E; Cebu Institute of Medicine, Cebu City, Philippines., Aguirre Z; Cebu Institute of Medicine, Cebu City, Philippines., Ybañez MJC; Cebu Institute of Medicine, Cebu City, Philippines., Rubia JMM; Cebu Institute of Medicine, Cebu City, Philippines., Galang DJ; Cebu Institute of Medicine, Cebu City, Philippines., Lumbang GN; Cebu Institute of Medicine, Cebu City, Philippines., Ruyeras JMMJ; Cebu Institute of Medicine, Cebu City, Philippines., Magalong JV; College of Medicine, San Beda University, Manila, Philippines., Pine PL; Ateneo School of Medicine and Public Health, Manila, Philippines., Amigo JAC; Ateneo School of Medicine and Public Health, Manila, Philippines., Ansay MFM; Department of Family Medicine, University of Pittsburgh Medical Center (UPMC) McKeesport, McKeesport, PA, USA., Zelenkov N; Department of Family Medicine, University of Pittsburgh Medical Center (UPMC) McKeesport, McKeesport, PA, USA., Thomas SS; Arizona State University, Tempe, AZ, USA., Vijayaraghavan K; University of Arizona, Tucson, AZ, USA.

المصدر: Current medical research and opinion [Curr Med Res Opin] 2024 Sep; Vol. 40 (9), pp. 1495-1514. Date of Electronic Publication: 2024 Jul 27.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/adverse effects , Glucagon-Like Peptides*/therapeutic use , Diabetes Mellitus, Type 2*/drug therapy, Humans ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Randomized Controlled Trials as Topic ; Obesity/drug therapy ; Female ; Male